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Gaseous signaling molecules such as hydrogen sul-
fide (H2S)areproducedendogenouslyandmediateef-
fects through diverse mechanisms. H2S is one such
gasotransmitters that regulates multiple signaling
pathways in mammalian cells, and abnormal H2S
metabolism has been linked to defects in bone ho-
meostasis. Here, we demonstrate that bone marrow
mesenchymal stem cells (BMMSCs) produce H2S
in order to regulate their self-renewal and osteogenic
differentiation, and H2S deficiency results in defects
in BMMSC differentiation. H2S deficiency causes
aberrant intracellular Ca2+ influx because of reduced
sulfhydration of cysteine residues on multiple Ca2+
TRP channels. This decreased Ca2+ flux downregu-
lates PKC/Erk-mediated Wnt/b-catenin signaling
whichcontrolsosteogenicdifferentiationofBMMSCs.
Consistently, H2S-deficient mice display an osteopo-
rotic phenotype that can be rescued by small mole-
cules that release H2S. These results demonstrate
that H2S regulates BMMSCs and that restoring H2S
levels via nontoxic donors may provide treatments
for diseases such as osteoporosis that can arise
from H2S deficiencies.
INTRODUCTION
Hydrogen sulfide (H2S) is a colorless and poisonous gas with the
characteristic foul odor of rotten eggs. Recent studies showed
that H2S serves as a gasotransmitter in order to regulate a variety
of signaling pathways (Wang, 2003). Physiologically, H2S plays
an important role in the induction of hippocampal long-term
potentiation, brain development, blood pressure regulation,
and inflammatory responses (Fiorucci et al., 2005; Li et al.,
2006; Olson and Donald, 2009; Yusuf et al., 2005; Zhong et al.,
2003). Abnormal H2S metabolism has been linked to several66 Cell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc.human diseases, including Alzheimer’s disease, hypertension,
coronary heart disease, atheroscerosis, cataracts, pancreatitis,
and type I diabetes (Donovan et al., 2011; Gil et al., 2011; Li
et al., 2005).
In mammals, H2S is generated from L-cysteine catalyzed by
two pyridoxal-50-phosphate-dependent enzymes, termed cys-
tathionine b-synthase (CBS) and cystathionine g-lyase (CSE)
(Bukovska et al., 1994; Erickson et al., 1990; Swaroop et al.,
1992; Wang, 2002). CBS and CSE expression has been identi-
fied in many human and other mammalian cells, including those
from liver, kidney, brain, smooth muscle, pancreas, and lympho-
cytes (Stipanuk and Beck, 1982; Tang et al., 2006). CBS is
reported to be the predominant H2S-generating enzyme in the
brain and nervous system, and CSE is mainly expressed in the
vascular smooth muscles and pancreas (Abe and Kimura,
1996; Bao et al., 1998; Simpson and Freedland, 1976).
CBS deficiency is an autosomal recessive disease that is the
most frequent cause of clinical hyperhomocysteinemia and ho-
mocystinuria (Uren et al., 1978; Watanabe et al., 1995). Patients
may have multisystem disorders, including dislocated lenses,
mental deficiency, premature arteriosclerosis, thrombosis, and
osteoporosis. Epidemiological and clinical studies suggest
that hyperhomocysteinemia patients have an increased risk of
fracture (Dhonukshe-Rutten et al., 2005; Gjesdal et al., 2007;
McLean et al., 2004; van Meurs et al., 2004). However, the etiol-
ogy for the increased prevalence of osteoporosis in these
patients remains unclear. Although a high serum level of homo-
cysteine (HCY) hasbeenconsideredasoneof the factors causing
osteoporosis in these patients, controversial reports on the
effects of high levels of HCY on osteoclasts and osteoblasts
havemade it difficult to uncover the precise mechanism. In addi-
tion to elevated HCY, CBS-deficient patients also have a notably
reduced H2S level. Therefore, we hypothesize that a stable, low
level of H2S in the human body may play an important role in
maintaining the homeostasis of the bone marrow system.
Bone marrow mesenchymal stem cells (BMMSCs) are nonhe-
matopoietic multipotent stem cells and play an important role
in maintenance of the bone marrow homeostasis (Friedenstein
et al., 1974; Pittenger et al., 1999; Prockop, 1997). BMMSCs
and BMMSC-derived osteoblasts are responsible for bone
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H2S and Mesenchymal Stem Cell Differentiationformation and balancing osteoclast-mediated bone resorption in
order to maintain bone mineral density (BMD). It is unknown
whether BMMSCs produce H2S or whether H2S levels affect
BMMSC function. In this study, we show that BMMSCs express
both CBS and CSE and produce H2S. More importantly, H2S is
required to maintain stem cell properties in BMMSCs.
RESULTS
BMMSCs Express CBS and CSE and Produce H2S
Because H2S plays important biological roles in a variety of cell
types, we hypothesized that H2S may affect BMMSC function.
Interestingly, we found that both human and mouse BMMSCs
expressed CBS and CSE, as assessed by western blotting,
RT-PCR, and immunostaining (Figures 1A–1C). Double immuno-
staining showed that BMMSCs coexpressed CD73, a mesen-
chymal stem cell marker, with CBS and CSE (Figures 1D and
1E). BMMSCs were also able to produce H2S in culture superna-
tant at a level of 8–10 mM, which was upregulated by the treat-
ment of H2S donor NaHS and downregulated by the treatment
of the CBS inhibitor hydroxylamine (HA) or the CSE inhibitor D,
L-propargylglycine (PAG) (Figure 1F; Figure S1A available on-
line). However, combined treatment with HA and PAG showed
the same H2S reduction as observed in the groups that received
only HA or PAG (Figure 1F). Moreover, we revealed that mouse
serum H2S levels were upregulated by intraperitoneal (i.p.) injec-
tion of NaHS and downregulated by i.p. injection of HA or PAG
(Figure 1G). Combined injection of HA and PAG showed similar
downregulated H2S levels to ones observed in the HA or PAG
groups (Figure 1G). These data indicate that BMMSCs express
both CBS and CSE and produce H2S. H2S production by
BMMSCs is upregulated by H2S donor and downregulated by
H2S inhibitor. In addition to expressing CBS and CSE, both
human and mouse BMMSCs express 3-mercaptopyruvate sul-
furtransferase (3-MST) and cysteine aminotransferase (CAT),
as shown by western blotting, RT-PCR, immunocytostaining,
and flow cytometric analysis (Figures S1B–S1F). When expres-
sion of either 3-MST or CAT was knocked down by small inter-
fering RNA (siRNA), H2S production by BMMSCs was partially
reduced, and their in vitro osteogenic differentiation was
impaired, as assessed by alizarin red staining (Figures S1G–S1I).
H2S Is Required for Maintenance of BMMSC Function
In Vivo
To examine whether H2S serves as a physiologic gasotransmit-
ter for regulating stem cell properties, we used CBS knockout
mice as an H2S-deficient model to examine BMMSC function
(Watanabe et al., 1995). A previous study showed that CBS
knockout mice had a cartilage deficiency, but it was not reported
whether they also had osteogenic disorder (Watanabe et al.,
1995). We revealed that CBS–/– mice displayed several abnor-
malities, including severe growth retardation and developmental
defects (Figure S2A), which led to death at 4 weeks of age in
most cases (Watanabe et al., 1995). CBS+/– mice survived nor-
mally, and only 1 of 50mice showed the reduction in bodyweight
and loose hair that was observed in CBS–/– mice (Figure S2A).
CBS protein was absent in CBS–/– BMMSCs and decreased to
half of normal levels in CBS+/– BMMSCs (Figure S2B). Endoge-
nous H2S levels in serum showed a 50% reduction in bothCBS–/– and CBS+/– mice in comparison to normal C57BL6
mice (Figure 2A), which may indicate production of H2S with
CSE as an alternative enzyme. Furthermore, we revealed that
cultured CBS–/– and CBS+/– BMMSCs produced similarly
reduced levels of H2S (Figure 2B). All CBS
–/– mice and 66.6%
of CBS+/– mice had osteopenia phenotypes, as assessed by
histological analysis, which showed reduced femur trabecular
bone volume (Figure 2C), and microCT analysis, which showed
reduced BMD and bone volume/tissue volume (BV/TV) in femurs
(Figure 2D).
Because it is unknown whether CBS deficiency affects
BMMSCs, we next revealed that CBS–/– and CBS+/– BMMSCs
showed increased proliferation rates (Figures 2E).When cultured
under osteoinductive conditions, CBS–/– and CBS+/– BMMSCs
showed reduced capacities for mineralized nodule formation,
expression of the osteogenic makers Runt-related transcription
factor 2 (Runx2) and alkaline phosphatase (ALP), and regen-
eration of new bone when subcutaneously implanted into immu-
nocompromised mice (Figures 2F and 2G). However, when
induced under adipogenic conditions, CBS–/– and CBS+/–
BMMSCs showed adipogenic differentiation capacities similar
to that observed in normal BMMSCs, as assessed by Oil Red
O staining, to show the number of adipocytes and RT-PCR to
show expression levels of lipoprotein lipase (LPL) and peroxi-
some proliferator-activated receptor g 2 (PPARg2) (Figure S2C).
Interestingly, elevating H2S levels in CBS
+/– BMMSCs by
in vitro H2S donor NaHS treatment was able to rescue their cell
proliferation rate, capacity for mineralized nodule formation,
expression of osteogenic markers Runx2 and ALP, and capacity
for in vivo bone formation (Figures 3A–3C). However, H2S donor
NaHS treatment failed to affect adipogenic differentiation in
CBS+/– BMMSCs, as shown by Oil Red O staining and RT-PCR
to show expression levels of LPL and PPARg2 (Figure S3A).
These data imply that H2S is required for maintaining stem cell
properties of BMMSCs.
H2S Is Required for Maintenance of BMMSC Function
In Vitro
Next, we used an in vitro culture system to examine the role of
H2S in BMMSC proliferation and differentiation. When treated
with the CBS inhibitor HA, the CSE inhibitor PAG, CBS siRNA,
or CSE siRNA to reduce H2S levels, BMMSCs showed a similar
phenotype to the one observed in CBS+/ BMMSCs, including
increased proliferation rate, reduced capacity for forming miner-
alized nodules in vitro, downregulation of Runx2 and ALP, and
reduced new bone formation when implanted into immuno-
compromisedmice subcutaneously (Figures 3D–3F). In contrast,
reducing H2S levels in BMMSCs with CBS inhibitor, CSE inhibi-
tor, or CBS siRNA treatment showed no effect on their adipo-
genic differentiation (Figures S3B–S3D). These data confirm
that H2S is required to maintain BMMSC self-renewal and oste-
ogenic differentiation.
Elevation of H2S Level in CBS
+/– Mice Rescues
Osteopenia Phenotype and BMMSC Function
In order to examine whether H2S donor treatment rescues
BMMSC function and osteopenia phenotype in H2S-deficient
mice, H2S donor GYY4317 was i.p. injected into CBS
+/– mice
every other day at 1 mg per mouse for 28 days (a total ofCell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc. 67
A B C
D E
F G
Figure 1. BMMSCs Produced H2S
(A and B) Both human (h) and mouse (m) BMMSCs express CBS and CSE, as assessed by western blotting (A) and RT-PCR (B).
(C) Immunocytochemical staining confirmed that both human and mouse BMMSCs expressed CBS and CSE.
(D and E) Double immunostaining (D) and flow cytometric analysis (E) showed that 30% of CBS- and 23% of CSE-positive mouse BMMSCs expressed
mesenchymal stem cell marker CD73.
(F) Mouse BMMSC culture supernatant contained around 20 mM H2S. H2S levels were immediately upregulated by H2S donor NaHS (100 mM) treatment and
downregulated by CBS inhibitor hydroxylamine (HA, 100 mM) or CSE inhibitor D, L-propargylglycine (PAG, 100 mM) treatment for 24 hr. When same amount of HA
and PAG were added to the culture, the reduction of H2S levels were the same as HA and PAG group.
(G) The normal H2S level in C57BL6mouse serum is about 16.2 mM. H2S levels were immediately elevated upon i.p. injection of H2S donor NaHS and reduced by
i.p. injection of CBS inhibitor HA or CSE inhibitor PAG treatment for 24 hr. Combinative i.p. injection of the same amount of HA and PAG showed the same levels of
H2S reduction as observed in HA and PAG group. *p < 0.05, **p < 0.01. The bar represents 50 mm. Experiments were repeated three times.
See also Figure S1.
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H2S and Mesenchymal Stem Cell Differentiation14 injections) (Figure4A).After the last injection, serumH2S levels,
femur trabecular bone volume, BMD, and BV/TV were signifi-
cantly increased in CBS+/– mice (Figures 4B–4D). Additionally,
BMMSCs from GYY4317-treated CBS+/– mice showed signifi-
cant rescue of cell proliferation rate, capacity to formmineralized
nodules, expression of the osteogenic markers Runx2 and ALP,
and formation of new bone in vivo in comparison to the untreated68 Cell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc.CBS+/– BMMSCs (Figures 4E–4G). As expected, GYY4317
treatment failed to affect adipogenic differentiation of CBS+/–
BMMSCs, as evaluated by the number of Oil RedO-positive cells
andexpression levels ofLPLandPPARg2 (FiguresS4AandS4B).
These results indicate that elevation of H2S levels by H2S donor
treatment is capable of rescuing the osteopenia phenotype and
osteogenic deficiency of BMMSCs in CBS+/– mice.
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Figure 2. H2S-Deficient Mice Showed Osteopenia Phenotype and BMMSC Impairment
(A) Serum H2S levels decreased by almost half in CBS
+/– mice in comparison to control C57BL6 mice (WT). Although serum H2S levels in CBS
–/– mice were lower
than they were in CBS+/– mice, no significant difference was observed between CBS+/– and CBS–/– mice.
(B) H2S levels in the culture supernatant of CBS
+/– and CBS–/– BMMSCs showed a reduction to half that of the normal BMMSC group (WT). No cell, background
control.
(C) Femur trabecular bone volume in 66.6% of CBS+/– mice and all CBS–/– mice was significantly reduced (yellow square) in comparison to C57BL6mice (WT), as
evaluated by hematoxylin and eosin staining analysis.
(D) Osteopenia phenotype was confirmed in CBS+/– and CBS–/– mice by microQCT analysis. CBS+/– and CBS–/– mice showed significantly reduced bone mineral
density (BMD) and bone volume/tissue volume (BV/TV) in comparison to C57BL6 mice (WT).
(E) BrdU labeling assay showed that CBS+/– and CBS–/– BMMSCs had increased proliferation rates when compared to normal BMMSCs (WT).
(F) When cultured under osteogenic inductive conditions, CBS+/– and CBS–/– BMMSCs showed reduced capacities to form mineralized nodules (evaluated by
alizarin red staining) and express osteogenic markers Runx2 and ALP (evaluated by western blotting).
(G) When BMMSCs were subcutaneously implanted into immunocompromised mice with hydroxyapatite tricalcium phosphate (HA/TCP; HA) as a carrier, new
bone regeneration was reduced in CBS+/– and CBS–/– BMMSC implants compared to normal BMMSC implants (WT). CT, connective tissue.
*p < 0.05, **p < 0.01. The bar represents 1,000 mm (C) and 200 mm (G). Experiments were repeated three times. See also Figure S2.
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H2S and Mesenchymal Stem Cell DifferentiationCBS Inhibitor HA and CSE Inhibitor PAG Treatment
Resulted in Osteopenia Phenotype and BMMSC
Impairment In Vivo
Next, we examined whether injection of CBS inhibitor to reduce
H2S levels would cause osteopenia phenotype and BMMSCimpairment, as observed in CBS+/– mice. When CBS inhibitor
HA was i.p. injected into C57BL6 mice every other day at
100 mg per mouse for 28 days (a total of 14 injections), serum
H2S levels and CBS protein expression levels were significantly
decreased in comparison to the untreated control group (FiguresCell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc. 69
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Figure 3. H2S Levels Affected BMMSC Function In Vitro
(A and B) H2S donor NaHS (100 mM) treatment for 24 hr rescued impaired CBS
+/– BMMSCs (CBS+/–) function, as indicated by reduction of proliferation rate
evaluated by BrdU staining (A) and elevation of mineralized nodule formation evaluated by alizarin red staining, and increased expression of osteogenic marker
Runx2 and ALP, as evaluated by western blotting (B).
(C) When implanted into immunocompromised mice subcutaneously with HA/TCP (HA) as a carrier, NaHS-treated CBS+/– BMMSCs (CBS+/–+NaHS) showed
improved capacity to generate new bone and bone marrow (BM). Normal BMMSCs were used as a control.
(D–F) Moreover, we showed that blockage of H2S levels by CBS inhibitor (HA, 100 mM), CSE inhibitor (PAG, 100 mM), CBS siRNA, and CSE siRNA treatment for
24 hr resulted in increased proliferation rate, as evaluated by BrdU staining (D), but reduced mineralized nodule formation, as shown by alizarin red staining, and
reduced expression of osteogenic markers Runx2 and ALP, as shown by western blotting (E). Normal BMMSCs were used as a control.
(F) When implanted into immunocompromised mice subcutaneously using HA/TCP (HA) as a carrier, BMMSCs treated by HA, PAG, CBS siRNA, or CSE siRNA
showed reduction in the capacity to generate new bone in vivo. CT, connective tissue.
*p < 0.05, **p < 0.01. The bar represents 200 mm. Experiments were repeated three times. See also Figure S3.
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H2S and Mesenchymal Stem Cell Differentiation5A–5C). HA treatment resulted in a significant reduction in femur
trabecular bone area, BMD, and BV/TV in C57BL6 mice (Figures
5D and 5E). BMMSCs derived from HA-treated mice showed
the same phenotype observed in CBS+/ BMMSCs, including
increased proliferation rate, decreased capacity to formmineral-
ized nodules and expression of the osteogenic makers Runx2
and ALP as well as reduced new bone formation in vivo (Figures
5F–5I). However, HA treatment failed to affect the adipogenic
differentiation of BMMSCs (Figure 5J). These data suggest that
reduction of H2S levels may be directly associated with BMMSC
impairment and osteopenia phenotype. Moreover, when
CSE inhibitor PAG was i.p. injected into C57BL6 mice every
other day at 100 mg per mouse for 28 days (a total of 14 injec-
tions) (Figure S5A), serumH2S levels andCSE protein expression
levels were significantly decreased in comparison to the un-
treated control group (Figures S5B and S5C). PAG treatment
resulted in a significant reduction in femur trabecular bone
area, BMD, and BV/TV in C57BL6 mice (Figures S5D and S5E).70 Cell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc.BMMSCs derived from PAG-treated mice showed the same
phenotype observed in CBS+/ BMMSCs, including increased
proliferation rate and decreased capacity to form mineralized
nodules and expression of the osteogenic makers Runx2 and
ALP as well as reduced new bone formation in vivo (Figures
S5F–S5H).
H2S Level, but Not Homocysteine Accumulation, May
Contribute to BMMSC Impairment in CBS-Deficient
Mice
CBS-deficiency-induced homocysteine accumulation may
contribute to diseased phenotypes in CBS-deficient patients
(Gaustadnes et al., 2000; Kelly et al., 2003; Kluijtmans et al.,
1999; Maclean et al., 2002; Miles and Kraus, 2004). In order
to clarify whether homocysteine accumulation affects BMMSC
function in CBS-deficient conditions, we assessed plasma
homocysteine levels in CBS-deficient mice and found that
CBS–/– mice had 343 greater plasma homocysteine levels than
A B C
D E
F G
Figure 4. Intraperitoneal Injection of H2S Donor GYY4317 Rescued Osteopenia Phenotype and BMMSC Function in CBS
+/– Mice
(A) H2S donor GYY4317 was i.p. injected to CBS
+/– mice every other day at 1 mg per mouse for 28 days (a total of 14 times). After the last injection, the samples
were harvested for additional experiments.
(B–D) After GYY4317 treatment, CBS+/– mice showed significantly increased serum H2S levels (B), femur trabecular bone volume, as shown by H&E staining (C),
BMD and bone volume/tissue volume (BV/TV), as shown by microQCT (D). Wild-type mice were used as control (WT).
(E–H) When compared to CBS+/– BMMSCs (CBS+/–), BMMSCs from GYY4317-treated CBS+/– mice (CBS+/–+GYY4317) showed reduced proliferation as
evaluated by BrdU labeling (E), elevated mineralized nodule formation shown by alizarin red staining, elevated expression of osteogenic markers Runx2 and ALP
(F), and increased new bone formation when implanted into immunocompromised mice subcutaneously with HA-TCP as a carrier (HA). CT, connective tissue (G).
Wild-type mice were used as control (WT).
*p < 0.05, **p < 0.01. The bar represents 1,000 mm (C) and 200 mm (G). Experiments were repeated three times. See also Figure S4.
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H2S and Mesenchymal Stem Cell Differentiationage-matched C57BL6 wild-type (WT) mice. However, CBS+/–
mice, which have an osteopenia phenotype similar to CBS–/–
mice, showed plasma homocysteine levels only twice as high
as age-matched C57BL6 WT mice (Figures S5I and S5J). Both
CBS–/– and CBS+/– mice showed elevated numbers of tartrate-
resistant acid phosphatase (TRAP)-positive osteoclasts in their
femurs and elevated receptor activator of nuclear factor kB
(NF-kB) ligand (RANKL) levels in serum in comparison to WT
control mice. However, CBS–/– mice exhibited a more significant
increase in the number of TRAP-positive osteoclasts and higher
levels of RANKL than CBS+/– mice (Figures S5K and S5L). These
data suggest that homocysteine levels may be associated
with osteoclast activity. Although i.p. injection of H2S donor
GYY4317 rescued the osteopenia phenotype and BMMSC func-
tion in CBS+/– mice, it failed to reduce serum homocysteine
levels in CBS+/– mice (Figure S5M). These data suggest that
H2S levels may affect the osteopenia phenotype via regulating
BMMSC differentiation in CBS-deficient mice. Although i.p. in-
jection of CBS inhibitor reduced H2S levels and resulted in an
osteopenia phenotype in C57BL6 mice (Figures 5L and 5M),
only slightly elevated serum homocysteine levels was observed
(Figure S5N), confirming that H2S levels affect the osteopenia
phenotype. To determine whether homocysteine has any directeffect on BMMSCs, we used a dose of 100–200 mM homocys-
teine to treat BMMSCs in vitro and found that the treatment failed
to affect cell proliferation, in vitro mineralized nodule formation,
and in vivo bone formation of BMMSCs (Figures S5). This exper-
imental evidence suggests that H2S levels, but not homocyste-
ine, may directly affect BMMSC function. In addition, we showed
that in vitro NaHS treatment resulted in reduced numbers of
osteoclasts, whereas homeocysteine treatment increased oste-
oblast numbers (Figure S5R).
H2S Deficiency Causes BMMSC Impairment via
Attenuation of Ca2+ Influx
H2S serves as a gasotransmitter to control cellular Ca
2+ levels,
which, in turn, regulate cell biological signaling (Distrutti, 2011;
Li et al., 2011; Ogawa et al., 2012). We showed that H2S donor
NaHS treatment induced a concentration-dependent Ca2+ influx
in BMMSCs (Figure 6A). H2S-induced Ca
2+ elevation mainly
resulted fromCa2+ influx with a limited contribution from intracel-
lular Ca2+ storage (Figure 6B). Single TRP channel knockdown
by siRNA for the TRPC subfamily (TRPC1, TRPC3, and TRPC7),
TRPV subfamily (TRPV1 and TRPV4), and TRPM subfamily
(TRPM2, TRPM4, and TRPM8) failed to block H2S-induced
(NaHS 100 mM) Ca2+ influx in BMMSCs (Figures S6A–S6L). NoCell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc. 71
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Figure 5. Intraperitoneal Injection of CBS Inhibitor Induced Osteopenia Phenotype and BMMSC Impairment
(A) CBS inhibitor HA was i.p. injected to C57BL6 mice every other day at 100 mg per mouse for 28 days (a total of 14 injections) and after that BMMSCs were
isolated.
(B and C) HA injection resulted in significantly reduced levels of H2S (B) and expression of CBS, as assessed by western blotting (C).
(D and E) HA injection induced marked reduction in mouse femur trabecular bone volume as assessed by H&E staining (D) and BMD as well as BV/TV, as
assessed by microQCT analysis (E).
(F and G) BMMSCs derived from HA-treated mice showed increased proliferation rates, as assessed by BrdU labeling (F), and increased mineralized nodule
formation, as shown by alizarin red staining, and increased expression of osteogenic markers Runx2 and ALP, as shown by western blotting (G).
(H) BMMSCs from HA-treated mice showed decreased capacity to generate new bone when implanted into immunocompromised mice subcutaneously using
HA/TCP (HA) as a carrier. BM: bone marrow; CT: connective tissue.
(I) BMMSCs from HA-treated mice showed no change in the number of Oil Red O-positive cells or expression of LPL and PPARg2 in comparison to untreated
control group.
*p < 0.05, **p < 0.01. The bar represents 1,000 mm (D) and 200 mm (H). Experiments were repeated three times. See also Figure S5.
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H2S and Mesenchymal Stem Cell Differentiationsignificant difference was observed in the amount of Ca2+ influx
among the different groups (Figure S6M). These data suggest
that H2S may affect not only one specific TPR Ca
2+ channel but
rathermultiple different TRPCa2+ channels. Thus, we next tested
the effect of combinations of siRNA knockdown of three TRP
channels (TRPV6, TRPV3, and TRPM4) that contain cysteine
(Cys) residues with potential to undergo sulfhydration. Interest-
ingly, we found that knockdown of TRPV6, TRPV3, and TRPM4
together blocked more than 50% of H2S-induced (NaHS
100 mM) Ca2+ influx in BMMSCs (Figure 6C). These results indi-
cate that H2S affects multiple TRP channels that may be associ-
ated with Cys residue sulfhydration.
Sulfhydryl Number in Ca2+ Channels Determines
H2S-Induced Ca
2+ Influx
H2S modifies specific Cys residues (–SH) in proteins through the
formation of a persulfide (–SSH) bond, and this modification has
been termed protein sulfhydration. The physiological function of
sulfhydration may be involved in the regulation of inflammation
and endoplasmic reticulum stress signaling as well as vascular
tension (Krishnan et al., 2011; Li et al., 2006). In order to further
explore whether H2S levels affect Ca
2+ channel sulfhydration in72 Cell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc.BMMSCs, the numbers of free Cys residues (sulfhydryl, –SH) on
cytomembrane between H2S-deficient and normal BMMSCs
were compared to classical Ellman’s reagent (Ellman, 1959).
Free sulfhydryls were found in decreased numbers in CBS+/–
BMMSCs in comparison to normal BMMSCs (Figure 6D). These
data demonstrate that the number of free sulfhydryls in BMMSC
membranes may correlate with H2S-induced Ca
2+ influx. Next,
we used chemical agent treatment to alter the number of free
sulfhydryls and measured whether this treatment affected
H2S-induced Ca
2+ influx. Dithiothreitol (DTT) can reduce the
disulfide bonds of proteins and increase the number of residual
sulfhydryl proteins (Cleland, 1964). In contrast, diamide (DM) is
capable of reducing the number of sulfhydryls (Kosower et al.,
1969), and (2-sulfonatoethyl) methanethiosulfonate (MTSES) is
a nonpermeable reagent able to reduce free sulfhydryls only
on the outer cytomembrane (Chen et al., 1997). In comparison
to the control group (Figure S6N), DTT-treated BMMSCs
showed an elevated amount of NaHS-induced Ca2+ influx
(Figure S6N). DM-treated BMMSCs showed a reduction in
NaHS-induced Ca2+ influx (Figure S6N). MTSES treatment
also decreased NaHS-induced Ca2+ influx in BMMSCs but did
not do so as effectively as the DM treatment (Figure S6N).
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Figure 6. H2S Regulated Ca
2+ Influx via Sulfhydration of Ca2+ Channels
(A) Ca2+ levels weremeasured from the ratio of emission in response to excitation at 340 and 380 nmbymicroscopy. H2S donor NaHS (10 mM to 10mM) induced a
dose-dependent Ca2+ influx in BMMSCs. Arrows represent the time points when H2S donor NaHS was added.
(B) When 100 mM NaHS, with or without 1 mM CaCl2, was used to treat BMMSCs, Ca
2+ flux only occurred in the presence of CaCl2, indicating that the calcium
influx mainly came from outside the cell membrane, but not from the endoplasmic reticulum or mitochondria.
(C) When combination knockdown of TRPV6, TRPV3, and TRPM4 expression was induced in BMMSCs by siRNA, NaHS-induced Ca2+ flux was significantly
reduced.
(D) Ellman’s test showed that sulfhydryl numbers on the cytomembrane were decreased in CBS+/– BMMSCs when compared to normal BMMSCs.
(E) Statistical analysis showed that 1 mM DTT treatment significantly elevated NaHS-induced Ca2+ influx, but 1 mM DM or MTSES significantly reduced NaHS-
induced Ca2+ influx when compared to the control group (100 mMNaHS treatment). DM treatment exhibited more effective inhibition of Ca2+ influx than MTSES.
(F) Ellman’s test showed DTT treatment increased the number of free sulfhydryls in BMMSCs, whereas DMdecreased the number of free sulfhydryls in BMMSCs.
MTSES also reduced the sulfhydryl number in the BMMSC membrane.
(G) Protein sulfhydration in BMMSCs, with or without NaHS treatment, was assessed by Alexa Fluor 488-conjugated C5 maleimide.
(H) After 1 mM DTT treatment, sulfhydration of TRPV6 protein was calculated on the basis of residual green fluorescence intensity in comparison to total level of
TRPV6 protein. Without NaHS treatment, DTT failed to affect the levels of ‘‘green’’ TRPV6 protein, indicating the absence of sulfhydration. In contrast, NaHS
treatment reduced the green signal of TRPV6 protein in the presence of DTT, indicating that sulfhydration occurred.
*p < 0.05, **p < 0.01. Experiments were repeated three times. See also Figure S6.
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levels of Ca2+ influx and free sulfhydryl in BMMSCs (Figures
6E and 6F). In contrast, DM and MTSES treatment induced
reduced levels of Ca2+ influx and free sulfhydryl in BMMSCs
(Figures 6E and 6F). These results suggest that the number of
free sulfhydryls, both inside and outside of the BMMSC cyto-
membrane, affects NaHS-induced Ca2+ influx. We used 1 mMof DTT, DM, and MTSES to treat BMMSCs for 15 min, which
failed to affect cell viability (data not shown).
Sulfhydration is a physiological process whereby H2S
attaches an additional sulfur to the sulfhydryl (–SH) groups of
Cys, yielding a hydropersulfide (–SSH) (Krishnan et al., 2011).
In order to examine whether H2S affects sulfhydration of Ca
2+
TRP channels, we used a modified Alexa Fluor 488-conjugatedCell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc. 73
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H2S and Mesenchymal Stem Cell DifferentiationC5 maleimide (green maleimide) assay to detect sulfhydration.
Maleimide interacts selectively with sulfhydryl groups of Cys,
labeling both sulfhydrated and unsulfhydrated Cys. An advan-
tage of this method is that nitrosylated or oxidized Cys do not
react with maleimide. The samples were treated with DTT,
which selectively cleaves disulfide bonds and detaches the
green signal from sulfhydrated, but not unsulfhydrated, protein,
resulting in decreased fluorescence. We employed green malei-
mide to detect transient receptor potential (TRP) sulfhydration
in BMMSCs with or without H2S treatment (Figure 6G). First,
we selected TRPV6 as a representative TRP protein to examine
sulfhydration. The level of sulfhydration of TRPV6 was calcu-
lated on the basis of the residual green fluorescence intensity
in comparison to the total amount of TRPV6 protein, which
was regulated by DTT treatment (Figure 6H). We found that,
without H2S treatment, DTT did not affect the levels of ‘‘green’’
TRPV6 protein, indicating the absence of sulfhydration (Fig-
ure 6H). In contrast, H2S treatment reduced the green signal
in the presence of DTT, indicating that sulfhydration had
occurred in the TRPV6 protein. Furthermore, we employed
mass spectrometric (MS) analysis in order to identify the Cys
residue responsible for sulfhydration of TRPV6 proteins in
BMMSCs. We used online LC-Orbitrap MS and collision-
induced dissociation (CID) MS/MS to confirm that H2S
treatment converted SH to SSH at specific modification sites
(Figure S6O). The conversion leads to a defined mass change
of the peptide from protein disulfide isomerase digest, which
was directly measured with a high level of confidence by high-
resolution MS (Figure S6P). The mass shift suggested that
BMMSCs were modified by H2S through S-sulfhydration of
Cys residues. Then, we used CID fragmentation MS/MS to
localize the modification sites with single-amino-acid resolution.
Detection of precursor ions at high resolution and a nearly com-
plete series of fragmentation ions from CID allowed the accurate
sequencing and identification of a single site of modification.
Integrating MS and CID MS/MS results, Proteome Discoverer
1.3 automatically assigned potential modification sites with a
high level of confidence. After H2S treatment, we found that
Cys residues were sulfhydrated with a high level of confidence
at the C172 and C329 sites (Figures S6O and S6P). Next,
we generated TRPV6C172mu and TRPV6C329mu constructs
and overexpressed TRPV6, TRPV6C172mu, TRPV6C329mu, and
TRPV6C172+C329mu in BMMSCs (Figures S6Q and S6U). Over-
expression of TRPV6 could slightly increase Ca2+ influx, and
it activated Ca2+ downstream signaling p-PKC and active
b-catenin, along with the downregulation of p-Erk (Figures
S6R and S6S). At the functional level, overexpression of
TRPV6 in BMMSCs increased in vitro osteogenic differentiation
(Figure S6T). Overexpression of TRPV6C172+C329mu, but not
TRPV6C172mu or TRPV6C329mu, reduced H2S donor-induced up-
regulation of p-PKC and active b-catenin and in vitro osteogenic
differentiation in the TRPV6 group (Figures S6S and S6T). These
data suggest that, although H2S affects sulfhydration in multiple
Ca2+ channels, TRPV6 C172 and C329 contribute at least
partially to sulfhydration-controlled Ca2+ influx in BMMSCs. In
addition to TRPV6, we showed that other Ca2+ TRP channels,
including TRPV3 and TRPM4, were also assigned sulfhydration
sites with a high level of confidence at Cys residues via fluores-
cence western blotting and CID MS/MS (Figures S6V–S6X).74 Cell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc.These data suggest that multiple TRP Ca2+ channels are sulfhy-
drated after H2S treatment.
Reduction of H2S Levels Induced Osteogenic Deficiency
in BMMSCs via Wnt/b-Catenin Pathway
In order to examine how H2S-deficiency-induced reduction of
Ca2+ influx affects osteogenic differentiation of BMMSCs, we
analyzed three Ca2+ downstream pathways, including PCK/
Erk, PI3K/Akt/GSK3b, and CaMKII/calcineurine A cascades,
which are closely linked to Ca2+-associated regulation of oste-
ogenic differentiation (Li et al., 2011; Lo¨f et al., 2012). We found
that expression levels of p-PKC significantly decreased
along with upregulation of p-ErK in CBS+/– BMMSCs and H2S
inhibitor-treated BMMSCs (Figure 7A). However, expression
levels of PI3K/Akt and CaMKII showed no difference between
CBS+/– and control BMMSCs (Figure S7A). Therefore, we
focused on assessing PCK/Erk signaling and confirmed that
H2S-inhibitor-treated BMMSCs have decreased expression of
p-PCK and elevated expression of p-Erk (Figure 7A). In contrast,
H2S donor NaHS treatment induced upregulation of p-PKC
but downregulation of p-ERK in BMMSCs (Figure 7A). NaHS
treatment failed to upregulate p-PKC expression in BMMSCs
(Figure 7B). Given that Erk inhibitor treatment failed to affect
p-PKC expression in BMMSCs (Figure 7C), Erk might be down-
stream of the PKC pathway. Altogether, these data indicate that
H2S-regulated Ca
2+ influx affects p-PKC and p-Erk expression
in BMMSCs.
Because PKC phosphorylation can serve as part of the Wnt/
calcium pathway, which regulates osteogenic differentiation of
BMMSCs, we examined expression levels of total and active
b-catenin. We found that expression of b-catenin and active
b-catenin was decreased in both CBS+/ and H2S-inhibitor-
treated BMMSCs (Figure 7D). Moreover, when TOPflash and
its control FOPflash were transfected to normal and CBS+/–
BMMSCs, comparing the relative levels of luciferase activity
confirmed that the canonical Wnt/ b-catenin pathway was in-
hibited in CBS+/– BMMSCs (Figure 7E). Reduced b-catenin
levels in both CBS+/– and H2S-inhibitor-treated BMMSCs
were rescued by H2S donor NaHS treatment, again as as-
sessed by relative luciferase activity (Figure 7F). Interestingly,
PKC inhibitor treatment blocked NaHS-rescued b-catenin
expression in both CBS+/– and H2S-inhibitor-treated BMMSCs
(Figure 7G), suggesting that the PCK pathway may regulate
b-catenin expression under CBS-deficient conditions. Addition-
ally, we showed that PKC activator and ErK inhibitor treatment
rescued the osteogenic deficiency in CBS+/– and H2S-inhibitor-
treated BMMSCs, as assessed by alizarin red staining, western
blot analysis, and in vivo BMMSC implantation (Figures 7H–7J
and S7B). These data confirm that PCK and Erk pathways
contribute to H2S-deficiency-associated osteogenesis. More-
over, combinative knockdown of sulfhydration-associated of
Ca2+ channels TRPV6, TRPV3, and TRPM4, which reduced
NaHS-induced Ca2+ influx (Figure 6C), also resulted in upregu-
lation of P-Erk, along with downregulation of p-PKC and active-
b-catenin (Figure 7K). Moreover, combinative knockdown of
TRPV6, TRPV3, and TRPM4 in BMSMCs by siRNA resulted
in reduced mineralized nodule formation and expression of
osteocalcin and Runx2 (Figures S7C and S7D). NaHS treat-
ment failed to rescue altered expression of p-Erk, p-PKC,
A B C D E
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Figure 7. H2S Deficiency Downregulated Wnt/b-Catenin Pathway via Reduced Ca
2+ Influx in BMMSCs
(A) CBS+/– and H2S inhibitor HA (100 mM)-treated BMMSCs cultured for 24, 48, or 72 hr showed significant downregulation of p-PKC and upregulation of p-Erk.
In contrast, H2S donor NaHS (100 mM) treatment for 5, 30, or 60 min upregulated p-PKC and downregulated p-Erk in BMMSCs.
(B) When pretreated with 2APB (10 mM) and SKF-96365 (10 mM) for 15 min to block Ca2+ influx, NaHS treatment failed to upregulate p-PKC expression in
BMMSCs.
(C) Erk inhibitor (PD325901, 1 mM) treatment failed to affect p-PKC expression in BMMSCs, indicating that Erk might be the downstream the PKC signaling.
(D) When CBS inhibitor HA (100 mM) or CSE inhibitor PAG (100 mM) was used to reduce H2S levels, BMMSCs showed significant reduction in total and active
b-catenin expression at 3 days posttreatment.
(E) When TOPflash and control FOPflash were transfected into normal and CBS+/– BMMSCs, luciferase activity indicated that the canonical Wnt/ b-catenin
pathway was inhibited in CBS+/– BMMSCs in comparison to normal BMMSCs.
(F) Reduced b-catenin expression in both CBS+/– and H2S inhibitor HA (100 mM)-treated BMMSCs was rescued by H2S donor NaHS (100 mM) treatment, as
assessed by luciferase activity.
(G) Rescue of b-catenin expression by NaHS (100 mM) in both CBS+/– and HA (100 mM)-treated BMMSCs was blocked by PKC inhibitor (Go¨ 6976, 10 nM)
treatment, as assessed by luciferase activity.
(H and I) PKC activator and Erk inhibitor treatment rescued the osteogenic deficiency in both CBS+/ and HA-treated BMMSCs, as assessed by alizarin red
staining to show mineral nodule formation.
(J) In vivo BMMSC implantation showed that PKC activator and Erk inhibitor treatment rescued CBS+/ BMMSC-mediated new bone formation. HA, HA/TCP;
BM, bone marrow; CT, connective tissue.
(K) Western blotting showed that combinative knockdown of TRPV6, TRPV3, and TRPM4 channels by siRNA led to upregulation of p-Erk and downregulation of
p-PKC, active-b-catenin, and b-catenin.
(L) H2S donor NaHS treatment failed to rescue the altered expression of p-Erk, p-PKC, active-b-catenin, and b-catenin, as assessed by western blotting.
*p < 0.05, **p < 0.01. The scale bar represents 200 mm. Experiments were repeated three times. See also Figure S7.
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ure 7L), and also failed to affect knockdown-induced mineral-
ized nodule formation and expression of osteocalcin and
Runx2 (Figures S7C and S7D), indicating that H2S-induced
Ca2+ influx in BMMSCs was regulated by multiple Ca2+
channels, at least including TRPV6, TRPV3, and TRPM4, via
a sulfhydration manner.DISCUSSION
Reduction of H2S Levels Contributes to Osteopenia
Phenotype in CBS-Deficient Mice
Classic clinical features of untreated CBS-deficient patients
include a variety of phenotypes, including myopia, ectopia lentis,
mental retardation, thromboembolic disorders, andosteoporosis.Cell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc. 75
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tion of osseous microarchitecture, resulting in decreased bone
strength and increased risk of fragility fractures. This phenotype
is often observed in patients with hyperhomocysteinemia (Herr-
mann et al., 2005; Melton, 2003). Cell-culture studies have sug-
gested that high HCY levels may stimulate osteoclast activity
(Herrmann et al., 2005; Koh et al., 2006). Our data showed that
osteoclast activity was significantly increased in CBS-deficient
mice, inwhich bothHCYandRANKLmayenhanceosteoclast ac-
tivity. Theeffectof highHCY levelsonosteoblasts is controversial.
Increased concentrations of HCY may enhance cell apoptosis
through activation of the NF-kB pathway and impair osteogenic
differentiation in osteoblast cell line HS-5 (Koh et al., 2006). Other
reports showed that increased concentrations of HCY stimulate
primary human osteoblast differentiation (Herrmann et al., 2007,
2008) and may not damage the osteogenic function of preosteo-
blastic cells (Carmel et al., 1988; Sakamoto et al., 2005; Thaler
et al., 2010). In this study, we found that HCY treatment failed to
induceBMMSC impairment. AlthoughCBS–/–mice showedan in-
crease in serumHCY level to about 343 that of controls, whereas
the level in CBS+/– mice only doubled, both CBS–/– and CBS+/–
BMMSCs showed a marked impairment of osteogenic differenti-
ation alongwith an osteopenia phenotype. Therefore, we hypoth-
esize that BMMSC impairment, which may not be related to the
high level of HCY, also contributes to the osteopenia phenotype
observed in CBS-deficient mice.
In addition to the elevated levels of HCY, a CBS-deficient
condition results in a reduction in the H2S level. However, it was
unknown whether this reduced H2S level contributes to the
osteopenia phenotype. In this study, we revealed that elevating
H2S levels in CBS
+/– mice by H2S donor GYY4317 treatment
rescued the osteopenia phenotype but failed to significantly alter
the HCY level. In addition, CBS inhibitor treatment failed to
significantly elevate the HCY level but did result in an osteopenia
phenotype like the one observed in CBS+/– mice with marked
impairment of BMMSCs. Although intraperitoneal injection of
CBS inhibitor HA only partially reduced the expression level of
CBS, the same as observed in CBS+/ mice, the HA treatment
was capable of significant reducing the levels of H2S. These
data suggest that partial deficiency of CBS expression is capable
of reducingH2S levels, resulting in an osteopenia phenotype. The
reduction of H2S levels in the bone microenvironment plays a
critical role in CBS-deficiency-associated osteopenia, perhaps
through regulation of BMMSC functions.
H2S Regulates Ca
2+ Influx via Sulfhydration of TRP
Channels in BMMSCs
H2S-induced Ca
2+ influx was diminished in CBS-deficient
BMMSCs and CBS-inhibitor-treated BMMSCs, suggesting that
the H2S, at the physiological level, plays a critical role in main-
taining normal function of the Ca2+ channels in BMMSCs. The
mechanism underlying H2S control of different Ca
2+ channels
is unknown. Interestingly, when the number of sulfhydryl groups
on TRP channels was altered by DTT and DM treatment, H2S-
induced Ca2+ influx was significantly affected. These data sug-
gest that the number of sulfhydryl groups in Cys of multiple
TRP channels may regulate H2S-mediated Ca
2+ influx.
The unique function of a gasotransmitter, which differs from
classical signaling molecules in the body, lies in its ability to76 Cell Stem Cell 15, 66–78, July 3, 2014 ª2014 Elsevier Inc.permeatemembranes freely and target specificmolecules easily.
It has been widely accepted that a single ligand usually reacts
with one special Ca2+ channel. Here, we suggest that a physio-
logical level of H2S maintains the sulfhydryl levels in order to
ensure normal Ca2+ channel function. In the process of sulfhydra-
tion, the sulfhydryl group of a reactive Cys is modified to aSSH
group, resulting in increased reactivity of the Cys residue.
Conclusion
The functional role of H2S in different tissues is still not fully eluci-
dated. Our study indicates that physiological levels of H2S are
required tomaintain intercellular Ca2+ homeostasis by sulfhydra-
tion of multiple TRP channels in BMMSCs. Reduction of H2S
levels results in a cascade response in BMMSCs, including
altered Ca2+ channel sulfhydration, Ca2+ influx, Wnt/b-catenin
signaling, and osteogenic differentiation. The eventual result is
an osteoporosis phenotype. It is anticipated that advances in
understanding the role of H2S may lead to H2S-donor-based
therapeutic approaches for H2S-deficiency-related disorders
(Mancardi et al., 2009).
EXPERIMENTAL PROCEDURES
Animals
Female C57BL/6J and 129P2-Cbstm1Unc/J mice were purchased from the
Jackson Laboratory. Female immunocompromised mice (beige nude/nude
XIDIII) were purchased from Harlan Laboratories. All animal experiments
were performed under institutionally approved protocols for the use of animal
research (University of Southern California protocols 10874 and 10941).
Isolation of Mouse BMMSCs
Bonemarrow cells were flushed out from the bone cavities of femurs and tibias
with2%heat-inactivated fetal bovine serum (FBS;Equitech-Bio) inPBS.Single-
cell suspension of all nuclear cells was obtained by passing through 70 mm cell
strainer (BDBiosciences). All nuclear cellswere seeded at 153 106 into 100mm
culture dishes (Corning) and initially incubated for 48 hr at 37C in 5% CO2. To
eliminate the nonadherent cells, the cultures were washed twice with PBS.
The attached cells were cultured for 16 days. The BMMSCs were cultured
with alpha minimum essential medium (Alpha-MEM, Invitrogen) supplemented
with 20% FBS, 2 mM L-glutamine (Invitrogen), 55 mM 2-mercaptoethanol
(Invitrogen), 100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen).
Injection of H2S Donor and Inhibitor into Mice
H2S donor NaHS andGYY4317, CBS inhibitor HA, andCSE inhibitor PAGwere
i.p. injected into mice as described in Table S2. The samples were harvested
1 month later, and additional experiments were carried out.
Cytoimmunofluorescent Microscopy
The cells were subcultured on eight-well chamber slides (Nunc; 2 3 103 per
well) under the culture medium for 12 hr at 37C in 5%CO2. Then, the samples
were fixed in 4%parafomaldehyde followed by 0.01%Triton-100 treatment for
10 min. The samples were blocked with normal serum matched to secondary
antibodies and incubated with specific or isotype-matched mouse antibodies
(1:200) overnight at 4C. The samples were treated with Rhodamine/ fluo-
rescein isothiocyanate -conjugated secondary antibodies (1:200, Jackson
ImmunoResearch and Southern Biotechnology) and were mounted by means
of a Vectashield mounting medium containing DAPI (Vector Laboratories).
Sulfhydryl Groups Measured by Ellman’s Test
Ellman’s reagent (5,50-dithio-bis-[2-nitrobenzoic acid], DTNB) is used to quan-
titate free (reduced) sulfhydryl groups (–SH) by comparing them to a standard
curve of a sulfhydryl-containing compound, such as cysteine. Alternatively,
sulfhydryl groups can be assayed with the extinction coefficient of 2-nitro-
5-thiobenzoic acid (TNB; 14,150 M1 cm1 at 412 nm). Ellman’s reagent has
Cell Stem Cell
H2S and Mesenchymal Stem Cell Differentiationprovided a reliable method for measuring reduced cysteines and other free
sulfhydryls in solution. DTNB reacted with a free sulfhydryl group to yield a
mixed disulfide and TNB. The target of DTNB in this reaction is the conjugate
base (R–S) of a free sulfhydryl group. In brief, 4 mg DTNB was dissolved in
1 ml reaction buffer (0.1 M sodium phosphate [pH 8.0] containing 1 mM
EDTA). A set of test tubes was prepared, each containing 50 ml of Ellman’s re-
agent solution and 2.5 ml of reaction buffer. In order to analyze the sulfhydryl
groups in living cells, 500 ml of Ellman’s reagent solution was directly added
into each well of the culture plate, mixed, and incubated at room temperature
for 15 min. Then, the solution was collected, and absorbance was measured
at 412 nm. Cysteine hydrochloride monohydrate was used as a reference
standard.
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